These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6305671)

  • 1. The pharmacokinetics of ranitidine in patients with chronic duodenal ulceration: a comparison of responders and non-responders.
    McFadyen ML; Folb PI; Miller R; Marks IN; Moshal MG
    Eur J Clin Pharmacol; 1983; 24(4):441-7. PubMed ID: 6305671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of ranitidine in patients with chronic duodenal ulceration.
    McFadyen ML; Folb PI; Marks IN; Wright JP; Lucke W
    Scand J Gastroenterol Suppl; 1981 Jun; 69():109-13. PubMed ID: 6119772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and gastric secretory studies of ranitidine in man.
    Louis WJ; Mihaly GW; Hanson RG; Anderson A; McNeil JJ; Yeomans ND; Smallwood RA
    Scand J Gastroenterol Suppl; 1981 Jun; 69():11-7. PubMed ID: 6119773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin.
    Mohammed R; Holden RJ; Hearns JB; McKibben BM; Buchanan KD; Crean GP
    Gut; 1983 Jan; 24(1):61-6. PubMed ID: 6129180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric acid secretory response in Helicobacter pylori-positive patients with duodenal ulcer disease.
    Jacobson K; Chiba N; Chen Y; Barrientos M; James C; Riddell RH; Hunt RH
    Can J Gastroenterol; 2001 Jan; 15(1):29-39. PubMed ID: 11173324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of gastric acid inhibition by ranitidine in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Digestion; 1981; 22(3):119-25. PubMed ID: 6116636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical comparison of cimetidine and ranitidine.
    Brater DC; Peters MN; Eshelman FN; Richardson CT
    Clin Pharmacol Ther; 1982 Oct; 32(4):484-9. PubMed ID: 6288312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ranitidine in patients with chronic renal failure.
    McFadyen ML; Folb PI; Miller R; Keeton GR; Marks IN
    Eur J Clin Pharmacol; 1983; 25(3):347-51. PubMed ID: 6313378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of duodenal and gastric ulcer with ranitidine--a controlled, multicentre clinical trial.
    Gibinski K; Nowak A; Gabryelewicz A; Szalaj W; Hasik J; Klincewicz H; Pokora J; Radwan P; Kosecki P; Pachlewski J
    Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):64-9. PubMed ID: 6286274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
    Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
    Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Day-night and individual differences in response to constant-rate ranitidine infusion.
    White C; Smolensky MH; Sanders SW; Buchi KN; Moore JG
    Chronobiol Int; 1991 Feb; 8(1):56-66. PubMed ID: 1814603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid-secretory response and parietal cell sensitivity in patients with duodenal ulcer before and after treatment with sucralfate or ranitidine.
    Marks IN; Young GO; Tigler-Wybrandi NA; Bridger S; Newton KA
    Am J Med; 1989 Jun; 86(6A):145-7. PubMed ID: 2735330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine--a new H2-receptor antagonist.
    Woodings EP; Dixon GT; Harrison C; Carey P; Richards DA
    Gut; 1980 Mar; 21(3):187-91. PubMed ID: 6105117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of ranitidine in reducing gastric acid-secretion decreases with continued therapy.
    Prichard PJ; Jones DB; Yeomans ND; Mihaly GW; Smallwood RA; Louis WJ
    Br J Clin Pharmacol; 1986 Dec; 22(6):663-8. PubMed ID: 3567013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of intravenous ranitidine and its effect on gastric acid secretion stimulated by pentagastrin in the cirrhotic].
    Bretagne JF; Reymann JM; Tassou JJ; Allain H; Gosselin A; Gastard J
    Gastroenterol Clin Biol; 1983 Apr; 7(4):355-61. PubMed ID: 6135641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranitidine heals duodenal ulcers.
    Marks IN; Wright JP; Denyer M; Hatfield A; Girdwood AH; Lucke W
    S Afr Med J; 1982 Jan; 61(5):152-4. PubMed ID: 6277018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranitidine in duodenal ulcer: incidence of healing and effect of smoking.
    Korman MG; Hansky J; Merrett AC; Schmidt GT
    Dig Dis Sci; 1982 Aug; 27(8):712-5. PubMed ID: 6284459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of ranitidine in the management of duodenal ulcer: controlled and open comparison with cimetidine in 59 patients.
    Lishman AH; Record CO
    J Clin Gastroenterol; 1982 Oct; 4(5):421-4. PubMed ID: 6294175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of H2-receptor blockade by ranitidine on ulcer healing and gastric acid secretion in patients with gastric and duodenal ulcers.
    Forssell H; Koch G
    Eur J Clin Pharmacol; 1983; 25(2):195-8. PubMed ID: 6313376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ranitidine in the treatment of duodenal ulcer. Initial clinical experience with 33 patients].
    Noya G; Dettori G; Antona C; Niolu P; Muscas A; Marongiu G; Biglioli P
    Minerva Med; 1983 Mar; 74(13):691-3. PubMed ID: 6132353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.